Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Gregory D. Perry
Age : 59
Public asset : 34,800 USD
Linked companies : Merus N.V. - Finch Therapeutics Group, Inc. - Kala Pharmaceuticals, Inc.
Summary 
Presently, Gregory D. Perry holds the position of Chief Financial Officer for Finch Therapeutics Group, Inc.

He is also on the board of Kala Pharmaceuticals, Inc. and Merus NV.

In the past he held the position of Chief Financial Officer, Treasurer & Executive VP of ImmunoGen, Inc., Chief Financial Officer & Executive Vice President for Elixir Pharmaceuticals, Inc., Chief Financial & Business Officer at Sesen Bio, Inc., Chief Financial Officer of Invivo Therapeutics Holdings Corp., Chief Administrative Officer of Novelion Therapeutics, Inc., SVP-Finance, Business Development & Life Sciences at PerkinElmer, Inc. (United States), Chief Financial Officer & Senior Vice President for Transkaryotic Therapies, Inc., Chief Financial Officer for Domantis Ltd., Chief Financial & Administrative Officer at Aegerion Pharmaceuticals, Inc. and Chief Financial Officer & Vice President for GE Medical Systems, Inc.

Gregory D. Perry received an undergraduate degree from Amherst College.


Current positions of Gregory D. Perry 
NameTitle Since
Merus N.V.
(Biotechnology & Medical Research)
Vice Chairman 2018
Finch Therapeutics Group, Inc.
(Biotechnology & Medical Research)
Chief Financial Officer 2018
Kala Pharmaceuticals, Inc.
(Pharmaceuticals)
Independent Director 2018


Holdings of Gregory D. Perry 
NameEquities%Valuation
Kala Pharmaceuticals, Inc. (KALA)
(Pharmaceuticals)
20,0000.031%34,800 USD
Merus N.V. (MRUS)
(Biotechnology & Medical Research)
00.0000%0 USD
Finch Therapeutics Group, Inc. (FNCH)
(Biotechnology & Medical Research)
00.0000%0 USD


Gregory D. Perry: Personal Network 
Most Read News 
11/23ELON MUSK : Tesla's Musk exercises more options, sells shares worth $1.05 billion
RE
12/05MUKESH AMBANI : Indian salesmen threaten supply disruptions in protest against Reliance
RE
11/30JACK DORSEY : Jack Dorsey chases crypto, fintech dream post Twitter
RE
11/24JAMIE DIMON : Jamie Dimon jokes that JPMorgan will outlast China's Communist Party
RE
12/01JACK DORSEY : Dorsey-led Square rebrands to Block in nod to blockchain
RE
12/03CATHIE WOOD : Cathie Wood's ARK Innovation fund hits 13-month low in tech selloff
RE
11/26ELON MUSK : Tesla decides against state aid for German battery plant as Musk opposes subsidies
RE
12/02ELON MUSK : Musk exercises more options, sells Tesla shares worth $1.01 billion
RE
02:26pELON MUSK : Tesla's Musk says Biden's electric vehicle bill should not pass Congress
RE
11/23ERIK NORDSTROM : Nordstrom warns of supply shortages as holiday season approaches, shares plunge
RE
More news


© 2021 People and Ownership :   
Gregory D. Perry : Connections